GPT Healthcare Ltd (GPTHEALTH) — shareholding pattern, promoter holding, financials and share price
About GPT Healthcare Ltd (GPTHEALTH)
GPT Healthcare Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as GPTHEALTH and on the BSE under scrip code 544131. Its ISIN is INE486R01017.
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services [1]
GPT Healthcare Limited operates a chain of multispecialty hospitals in Eastern India, focusing on providing tertiary care services. Its core business includes specialties like oncology, cardiology, and nephrology with a strong presence in cities like Kolkata, Agartala, and Raipur.
The company's revenue reached INR 350.5 Cr for 9M FY26, marking a robust year-on-year growth of 12.12%. Despite this, EBITDA margins have come under pressure, declining to 18.6%, impacted by new hospital expansions.
Listed peers in Hospital: Shalby Ltd, Unihealth Hospitals Ltd, Gujarat Kidney & Super Speciality Ltd, KRM Ayurveda Ltd, Asarfi Hospital Ltd, Hannah Joseph Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹157.35 a share on 10 Jul 2026, GPT Healthcare Ltd (GPTHEALTH) was valued at a price-to-earnings ratio of 30.58x against an industry P/E of 61.73x and a price-to-book of 5.21x on a book value of ₹30.21 per share as of Mar 2025. Solomo computes return on equity of 17.03% and return on capital employed of 22.26% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 30.58x
- Industry P/E
- 61.73x
- P/B
- 5.21x
- EPS (TTM)
- ₹5.15
- Book value / share
- ₹30.21
- ROE
- 17.03%
- ROCE
- 22.26%
- ROA
- 10.99%
- Debt / equity
- 0.14x
- Dividend yield
- 1.59%
- 52-week range
- ₹114 – ₹184.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2022In the year ended Mar 2022, GPT Healthcare Ltd (GPTHEALTH) reported revenue of ₹337 crore, net profit of ₹42 crore and earnings per share of ₹5.22. That compares with revenue of ₹243 crore and net profit of ₹21 crore in Mar 2021. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹126 crore and net profit ₹15 crore (standalone).
| Metric | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|
| Revenue (₹ cr) | 212 | 243 | 337 |
| Net profit (₹ cr) | 11 | 21 | 42 |
| EPS (₹) | 6.11 | 11.76 | 5.22 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 13.96% | 6.46% | 38.99% |
| Profit growth | 35.43% | 6.21% | 97.53% |
| Stock price CAGR | - | - | -12% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 65.57% of GPT Healthcare Ltd (GPTHEALTH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 3.03% and domestic institutional investors (DII) hold 6.94%. Market capitalisation was ₹1,291 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2024.
Largest disclosed public shareholders in Jun 2026: Bandhan Small Cap Fund 4.65%, India Capital Growth Fund Limited 2.74%, Rajasthan Global Securities Private Limited 1.2%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 65.57% | - | 3.03% | 6.94% | 34.43% |
| Mar 2026 | 65.57% | - | 2.81% | 6.83% | 34.43% |
| Dec 2025 | 65.57% | - | 2.74% | 6.2% | 34.43% |
| Sep 2025 | 65.57% | - | 3.2% | 6.46% | 34.43% |
| Jun 2025 | 65.57% | - | 4.96% | 9.32% | 34.43% |
| Mar 2025 | 65.57% | - | 4.48% | 11.35% | 34.43% |
| Dec 2024 | 65.57% | - | 4.72% | 11.3% | 34.43% |
| Sep 2024 | 65.57% | - | 4.7% | 11.99% | 34.43% |